Prelude Therapeutics Inc

PRLDNASDAQ · USD
3.96USD+0.05 (+1.28%)
1510

Prelude Therapeutics Inc (PRLD) Unusual Options Activity Today

PRLD options volume power reached 0x on the previous trading day. The highest reading was on the $5 CALL expiring 2026-10-16.

Read more

Checking PRLD unusual options activity helps you spot when traders are making outsized bets on Prelude Therapeutics Inc before the broader market catches on. Prelude Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PRLD unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PRLD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PRLD unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PRLD unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors.

The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.

Catalysts rarely arrive without a footprint, and PRLD unusual options activity is often where that footprint shows up first. Our scanner tracks Prelude Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PRLD unusual options volume on the call side or chasing put sweeps, Prelude Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
2.501.002.001.50185%00—
5.000.100.300.20152%06660.00%
7.50—0.700.70429%02040.00%
10.00—1.001.00592%020.00%
12.50—1.001.00646%00—
Puts
2.50—0.500.50396%00—
5.000.851.751.30159%0260.00%
7.503.204.203.70229%00—
10.005.706.706.20295%00—
12.508.209.208.70343%00—

As of September 28, 2026

Spot unusual options activity before it moves

Track PRLD options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial